10 December 2025 in ACS Nano
23 June 2025 in Biosensors and Bioelectronics
Accurate and timely diagnosis remains a major clinical challenge, hindered by the limitations of conventional histopathological methods, which often rely on labor-intensive staining protocols and subjective interpretation by specialized pathologists. These methods can fail to capture the full molecular and phenotypic heterogeneity of tumors, leading to increased diagnostic time, cost, and variability. To overcome these challenges, we developed a novel label-free ultraviolet (UV) microscopic imaging technique that exploits the intrinsic optical absorption properties of cellular nucleic acids and proteins. By modifying standard brightfield microscopes, our approach quantitatively measures the nucleic acid-to-protein ratio (NPr), enabling high-resolution visualization and discrimination between malignant and non-malignant cells without the need for exogenous labels or staining. We validated this technique using cultured pancreatic cell lines and tissue microarrays, demonstrating a significant elevation in NPr values in malignant samples. Diagnostic evaluation revealed a sensitivity of 82 % and specificity of 89 % for pancreatic cancer detection. This high-throughput, cost-effective, and minimally operator-dependent method offers a promising alternative to traditional histopathology, with potential applications in clinical diagnostics and cancer research. Our findings highlight the potential of UV NPr imaging to facilitate rapid, objective, and accurate cancer diagnosis, reducing reliance on subjective interpretation and complex sample preparation.
24 September 2024 in Heliyon
This research introduces a novel method for evaluating the structural features of biomolecules, utilizing our innovative Elliptical Dichroism (ED) spectrometer specifically designed for stereochemical analysis. By integrating ED spectrometry with autocorrelation (AC) analysis, we investigate the conformational characteristics of biological molecules such as amino acids, proteins, and extracellular vesicles (EVs) induced by elliptically polarized UV absorption. Our streamlined approach offers a cost-effective and portable solution with minimal sample consumption and supports multiple working modes to efficiently characterize biomolecular structures. The insight from this new approach demonstrates potential applications in using biomolecular characterization for cancer detection.
28 August 2022 in Scientific African
7 June 2026 in Biosensors and Bioelectronics
Current DNA structural analysis methods, such as X-ray crystallography, NMR, Circular Dichroism (CD) spectrometry, and Electron Microscopy (EM) provide accurate analysis of DNA structures; however, these methods are limited in their applicability due to their high cost, large size, and complexity of operation. To combat this, we invented Elliptical Dichroism Spectrometer (EDS), which is lower in cost, smaller in size, and handy for DNA structural analysis. Previously, we validated its use as a protein secondary structural analysis instrument with clinical potential for noninvasive cancer detection. Here, we validate EDS for DNA structural analysis using well-established fluorescence assays and circular dichroism spectroscopy. EDS demonstrates strong potential as a label-free alternative method for analyzing diverse DNA structures, including simple hairpins, complex G-quadruplexes, and various DNA origami architectures. Furthermore, EDS demonstrates proof-of-concept in biologically relevant systems for detecting diseases associated with DNA damage.